Inhibition of nitric oxide formation in inflammatory bowel disea

Details Inhibition of nitric oxide formation in inflammatory bowel disea Inhibition of nitric oxide formation in inflammatory bowel disea

1996-03-25

1998-01-20

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

A61K 31155

Patent

active

057101817

ABSTRACT:
A method is disclosed for inhibiting nitric oxide formation in a warm blooded mammal afflicted with inflammatory bowel disease which comprises administering to said mammal an effective nitric oxide inhibitory amount of aminoguanidine.

REFERENCES:
patent: 3541218 (1970-11-01), Marshall et al.
patent: 4758583 (1988-07-01), Cerami et al.
patent: 4870210 (1989-09-01), Musser
patent: 5128360 (1992-07-01), Cerami et al.
patent: 5246970 (1993-09-01), Williamson et al.
patent: 5246971 (1993-09-01), Williamson et al.
patent: 5273875 (1993-12-01), Griffith
patent: 5317040 (1994-05-01), Goldman et al.
patent: 5358969 (1994-10-01), Williamson et al.
Southan et al. (1996), Selective Pharmacological Inhibition of Distinct Nitric Oxide Synthase Isoforms, Biochemical Pharmacology 51:383-94.
Corbett et al. (1993), Nitric Oxide Mediates IL-1.beta.-Induced Islet Dysfunction And Destruction: Prevention By Dexamethasone, Autoimmunity 15:145-53.
Henrich (1990), Diabetes mellitus-ein Krankheitssyndrom und seine Behandlung, Pharm. Ztg. 135:1711-24.
Vlassara (1990), Chronic Diabetic Complications and Tissue Glycosylation Relevant Concern for Diabetes-Prone Black Population, Diabetes Care 13:1180-1185.
Bucala et al. (1991), Advanced Clycosylation Products Quench Nitric Oxide and Mediate Defective Endothelium-Dependent Vasodilatation in Experimental Diabetes, J. Clin. Invest. 87:432-438.
Brownlee et al. (1986), Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking, Science 232:1629-1632.
Corbett et al. (1992), Does Nitric Oxide Mediate Autoimmune Destruction of .beta.-Cells?, Diabetes 41:897-903.
Martindale, The Extra Pharmacopoeia, 28th ed., J.E.F. Reynolds, Ed., published by The Pharmaceutical Press (London), pp. 466, 467 and 473-477, 1982.
O'Connor et al., Biochim. Biophys. Acta., 1097(3), pp. 227-231 (Biosis Abs. No. 93030356), 1991.
Radomski et al., Proc. Natl. Sci USA, 87(24), pp. 10043-10047 (Biosis Abs. No. 91047745), 1990.

Affiliated with

Also associated with

Rating

Inhibition of nitric oxide formation in inflammatory bowel disea does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of nitric oxide formation in inflammatory bowel disea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of nitric oxide formation in inflammatory bowel disea will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-725783